Centrifuge has integrated Symbiotic's liquidity network across three tokenized funds representing approximately $1.6 billion in assets under management, giving eligible holders an additional route to exchange their positions for USDC, a US dollar stablecoin.

The integration covers Janus Henderson's JAAA, an AAA-rated collateralized loan obligation strategy; JTRSY, a short-duration US Treasury strategy; and New York Life Investment Management's HYB, a US high-yield corporate bond strategy.

Symbiotic's Liquid Lane operates as an onchain request-for-quote (RFQ) marketplace where market makers can draw liquidity from vaults — the same vault architecture Symbiotic uses in its core restaking business — to fill redemption requests. After acquiring fund tokens, market makers can either redeem them through the issuer or sell them via another RFQ transaction.

The arrangement lets investors receive USDC immediately, while the funds' normal redemption process takes place separately. That immediacy addresses a structural gap between conventional fund operations, which settle redemptions on scheduled cycles that can take days, and crypto markets that trade around the clock.

Platform growth driven by Janus Henderson

Centrifuge is an asset tokenization and vault platform where asset managers issue and manage tokenized funds. Janus Henderson, a global asset manager with roughly $500 billion in assets under management, has been a significant contributor to the platform's growth through its JAAA and JTRSY products.

By December 2025, Centrifuge had attracted about $1.3 billion in new inflows, driven primarily by the two Janus Henderson funds, according to Token Terminal. JAAA alone had contributed about $1 billion in total value locked and ranked among the largest tokenized funds in the market.

Those products sit within a tokenized fund sector that has expanded rapidly as conventional asset managers bring established strategies onchain — BlackRock, the largest asset manager, launched its BUIDL tokenized dollar fund in March 2024.

Symbiotic joins existing liquidity routes

Liquid Lane is not the first liquidity route available for Centrifuge's tokenized funds, Felix Lutsch, Symbiotic's head of ecosystem, told Cointelegraph.

"We're not claiming to be first, and other liquidity routes exist. That's healthy for the market," Lutsch said.

Centrifuge announced a partnership with Wintermute, a crypto market maker, in February 2025 to provide 24/7 instant redemptions for JTRSY. HYB launched in June with a separate liquidity arrangement enabling near-instant redemptions.

According to Lutsch, the distinction with Liquid Lane lies in the capital structure behind the transactions rather than their speed. The marketplace allows multiple market makers and curators to participate without market makers having to pre-fund and carry inventory for individual assets, he said.

"The bigger constraint has been flow," Lutsch said, noting that low trading volumes in tokenized assets have historically given market makers little incentive to commit capital.

He said aggregating redemption demand across issuers and asset classes could improve those economics as tokenized funds are increasingly used as collateral and financing assets in onchain markets.